104 related articles for article (PubMed ID: 24303784)
1. MST1/2 and YAP1 gene expression in acute myeloid leukemia.
Safari S; Movafagh A; Zare-Adollahi D; Ghadiani M; Riazi-Isfahani S; Safavi-Naini N; Omrani MD
Leuk Lymphoma; 2014 Sep; 55(9):2189-91. PubMed ID: 24303784
[No Abstract] [Full Text] [Related]
2. YAP1 expression in myelodysplastic syndromes and acute leukemias.
Machado-Neto JA; de Melo Campos P; Olalla Saad ST; Traina F
Leuk Lymphoma; 2014 Oct; 55(10):2413-5. PubMed ID: 24605912
[No Abstract] [Full Text] [Related]
3. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
4. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population.
Liu R; Wei C; Ma Q; Wang W
Pregnancy Hypertens; 2020 Jan; 19():1-10. PubMed ID: 31841877
[TBL] [Abstract][Full Text] [Related]
5. Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia.
Kapelko-Slowik K; Owczarek TB; Grzymajlo K; Urbaniak-Kujda D; Jazwiec B; Slowik M; Kuliczkowski K; Ugorski M
Leuk Lymphoma; 2016 Sep; 57(9):2140-9. PubMed ID: 26764044
[TBL] [Abstract][Full Text] [Related]
6. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
[TBL] [Abstract][Full Text] [Related]
7. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
[TBL] [Abstract][Full Text] [Related]
8. LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.
Shi Y; Geng D; Zhang Y; Zhao M; Wang Y; Jiang Y; Yu R; Zhou X
J Mol Neurosci; 2019 May; 68(1):38-48. PubMed ID: 30771084
[TBL] [Abstract][Full Text] [Related]
9. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N
Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874
[TBL] [Abstract][Full Text] [Related]
10. Assembly and activation of the Hippo signalome by FAT1 tumor suppressor.
Martin D; Degese MS; Vitale-Cross L; Iglesias-Bartolome R; Valera JLC; Wang Z; Feng X; Yeerna H; Vadmal V; Moroishi T; Thorne RF; Zaida M; Siegele B; Cheong SC; Molinolo AA; Samuels Y; Tamayo P; Guan KL; Lippman SM; Lyons JG; Gutkind JS
Nat Commun; 2018 Jul; 9(1):2372. PubMed ID: 29985391
[TBL] [Abstract][Full Text] [Related]
11. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
[TBL] [Abstract][Full Text] [Related]
12. YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29.
Tumaneng K; Schlegelmilch K; Russell RC; Yimlamai D; Basnet H; Mahadevan N; Fitamant J; Bardeesy N; Camargo FD; Guan KL
Nat Cell Biol; 2012 Dec; 14(12):1322-9. PubMed ID: 23143395
[TBL] [Abstract][Full Text] [Related]
13. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
14. Hippo-YAP and mTOR pathways collaborate to regulate organ size.
Csibi A; Blenis J
Nat Cell Biol; 2012 Dec; 14(12):1244-5. PubMed ID: 23196842
[TBL] [Abstract][Full Text] [Related]
15. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
16. MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
Cheng L; Wang H; Han S
Dig Dis Sci; 2017 Oct; 62(10):2812-2820. PubMed ID: 28823082
[TBL] [Abstract][Full Text] [Related]
17. Hippo on the move: tumor suppressor regulates adhesion and migration.
Artemenko Y; Devreotes PN
Cell Cycle; 2013 Feb; 12(4):535-6. PubMed ID: 23370390
[No Abstract] [Full Text] [Related]
18. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
19. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.
Yin H; Bogorad RL; Barnes C; Walsh S; Zhuang I; Nonaka H; Ruda V; Kuchimanchi S; Nechev L; Akinc A; Xue W; Zerial M; Langer R; Anderson DG; Koteliansky V
J Hepatol; 2016 Apr; 64(4):899-907. PubMed ID: 26658687
[TBL] [Abstract][Full Text] [Related]
20. The DeMSTification of mammalian Ste20 kinases.
Radu M; Chernoff J
Curr Biol; 2009 May; 19(10):R421-5. PubMed ID: 19467213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]